GPAGF yields 1.56% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GPAGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GPAGF + PFE for your $10,000?
Gruma, S.A.B. de C.V., together with its subsidiaries, produces and sells corn flour, tortillas, and other related products. The company offers corn flour, grits snacks and/or cereal, beer grits, and polenta; prepared corn or wheat flours for pancakes, cakes, crêpes, brownies, churros, pizza dough, cachapas, sweet arepitas, etc.; corn and wheat tortillas; tortilla chips, taco shells, and tostadas; flatbreads, including wraps, pita bread, naan, chapatti, pizza doughs, piadina, breakfast breads, and crackers; sauces/dips; palmito; pasta; marinades; and rice and oats. It markets and sells its products under the Maseca, Mission, Guerrero, Tosty, TortiRicas, Rumba, La Cima, Masa Rica, Del Fogón, Delicados, Arroz Luisiana, Tortimasa, Juana, Minsa, Mimasa, Bravos, Tronaditas, and Mexifoods brand names. The company also designs, manufactures, and commercializes machines for production of corn and wheat flour tortillas, and tortilla chips under the TORTEC and RODOTEC names; and designs and manufactures equipment for corn masa flour, such as corn milling machinery, as well as provides engineering, design, and construction services. It provides its products to retail customers, including supermarkets, mass merchandisers, membership stores, and independent stores; food service customers comprising chain restaurants, food service distributors, schools, hospitals, and military; and tortilla manufacturers and corn chip producers. The company distributes its products primarily through independent distributors and wholesalers. It has operations in Mexico, the United States, Central America, Europe, Asia, and Oceania. Gruma, S.A.B. de C.V. was founded in 1949 and is headquartered in San Pedro Garza García, Mexico.
Full GPAGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.